Compare Direxion NASDAQ 100 Equal Weighted Index Shares (QQQE) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion NASDAQ 100 Equal Weighted Index Shares vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Direxion NASDAQ 100 Equal Weighted Index Shares trades at $121.68 (market cap $1.45B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.79 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 17.4× Direxion NASDAQ 100 Equal Weighted Index Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Direxion NASDAQ 100 Equal Weighted Index Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Direxion NASDAQ 100 Equal Weighted Index Shares for 47 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| QQQE | RPRX | |
|---|---|---|
Market Cap | $1.45B | $25.27B |
Volume | 323,568 | 3,671,183 |
Sector | Broad Market / Factor | Health |
52-Week High | $124.69 | $63.96 |
52-Week Low | $96.06 | $35.44 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QQQE (Direxion NASDAQ-100 Equal Weighted Index ETF) trades at $121.58, down 0.25% on the day, with a bullish technical signal from moving averages while oscillators remain neutral. The ETF provides equal-weighted exposure to NASDAQ-100 companies, reducing technology concentration from 60% to 45% compared to market-cap weighted alternatives. Recent analysis suggests QQQE offers tactical advantages over QQQ for the next twelve months due to its equal-weight methodology.
The outlook for QQQE appears favorable as equal weighting provides diversification benefits amid potential tech sector volatility. Key risks include NASDAQ concentration and market sensitivity, but the ETF's structure offers balanced exposure to large-cap growth stocks. Technical support levels at $120-121 provide near-term downside protection.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Direxion NASDAQ 100 Equal Weighted Index Shares
QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
